Oncology Central

New horizons in ablation therapy for hepatocellular carcinoma


Historically ablative treatment for hepatocellular cancer (HCC) has been regarded as inferior to transplantation and resection and has therefore been reserved for patients not suitable for surgical intervention in stage 0-A HCC according to the Barcelona Clinic Liver Cancer classification system.

To view restricted content, please:

Leave A Comment